Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.

Saved in:
Bibliographic Details
Title: Measuring residual anti-Xa activity of direct factor Xa inhibitors after reversal with andexanet alfa.
Authors: Bourdin M; Diagnostica Stago R&D, Gennevilliers, France., Perrotin D; Diagnostica Stago R&D, Gennevilliers, France., Mathieu O; Diagnostica Stago R&D, Gennevilliers, France., Herve T; Diagnostica Stago Clinical and Pharmaceutical Development, Asnières-sur-Seine, France., Depasse F; Diagnostica Stago Clinical and Pharmaceutical Development, Asnières-sur-Seine, France., Lu G; Portola, a subsidiary of Alexion, South San Francisco, CA, USA., Conley PB; Portola, a subsidiary of Alexion, South San Francisco, CA, USA., Contant G; Diagnostica Stago R&D, Gennevilliers, France.
Source: International journal of laboratory hematology [Int J Lab Hematol] 2021 Aug; Vol. 43 (4), pp. 795-801. Date of Electronic Publication: 2021 Jun 05.
Publication Type: Journal Article
Journal Info: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 101300213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1751-553X (Electronic) Linking ISSN: 17515521 NLM ISO Abbreviation: Int J Lab Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1751-553X
DOI:10.1111/ijlh.13591